Gill DR - Search Results

1

Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury.

Ulrich K, Stern M, Goddard ME, Williams J, Zhu J, Dewar A, Painter HA, Jeffery PK, Gill DR, Hyde SC, Geddes DM, Takata M, Alton EW. Ulrich K, et al. Among authors: gill dr. Am J Physiol Lung Cell Mol Physiol. 2005 Jun;288(6):L1179-92. doi: 10.1152/ajplung.00450.2004. Epub 2005 Jan 28. Am J Physiol Lung Cell Mol Physiol. 2005. PMID: 15681392 Free article.

2

Drug efflux mediated by the human multidrug resistance P-glycoprotein is inhibited by cell swelling.

Sardini A, Mintenig GM, Valverde MA, Sepúlveda FV, Gill DR, Hyde SC, Higgins CF, McNaughton PA. Sardini A, et al. Among authors: gill dr. J Cell Sci. 1994 Dec;107 ( Pt 12):3281-90. doi: 10.1242/jcs.107.12.3281. J Cell Sci. 1994. PMID: 7706385

3

Tamoxifen blocks chloride channels. A possible mechanism for cataract formation.

Zhang JJ, Jacob TJ, Valverde MA, Hardy SP, Mintenig GM, Sepúlveda FV, Gill DR, Hyde SC, Trezise AE, Higgins CF. Zhang JJ, et al. Among authors: gill dr. J Clin Invest. 1994 Oct;94(4):1690-7. doi: 10.1172/JCI117514. J Clin Invest. 1994. PMID: 7929848 Free PMC article.

4

Chloride secretion in the trachea of null cystic fibrosis mice: the effects of transfection with pTrial10-CFTR2.

MacVinish LJ, Gill DR, Hyde SC, Mofford KA, Evans MJ, Higgins CF, Colledge WH, Huang L, Sorgi F, Ratcliff R, Cuthbert AW. MacVinish LJ, et al. Among authors: gill dr. J Physiol. 1997 Mar 15;499 ( Pt 3)(Pt 3):677-87. doi: 10.1113/jphysiol.1997.sp021960. J Physiol. 1997. PMID: 9130164 Free PMC article.

5

Towards gene therapy for cystic fibrosis: a clinical progress report.

Alton EW, Geddes DM, Gill DR, Higgins CF, Hyde SC, Innes JA, Porteous DJ. Alton EW, et al. Among authors: gill dr. Gene Ther. 1998 Mar;5(3):291-2. doi: 10.1038/sj.gt.3300655. Gene Ther. 1998. PMID: 9614547 No abstract available.

6

Measure and interpretation of CF gene therapy trial results.

Alton E, Geddes D, Gill D, Greening A, Higgins C, Hyde S, Innes JA, Porteous D, Stern M. Alton E, et al. Mol Ther. 2000 Jul;2(1):3-4. doi: 10.1006/mthe.2000.0097. Mol Ther. 2000. PMID: 10899820 Free article. No abstract available.

7

Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.

Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC. Gill DR, et al. Gene Ther. 2001 Oct;8(20):1539-46. doi: 10.1038/sj.gt.3301561. Gene Ther. 2001. PMID: 11704814

8

Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy.

Broackes-Carter FC, Mouchel N, Gill D, Hyde S, Bassett J, Harris A. Broackes-Carter FC, et al. Hum Mol Genet. 2002 Jan 15;11(2):125-31. doi: 10.1093/hmg/11.2.125. Hum Mol Genet. 2002. PMID: 11809721

9

Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways.

Rose AC, Goddard CA, Colledge WH, Cheng SH, Gill DR, Hyde SC. Rose AC, et al. Among authors: gill dr. Gene Ther. 2002 Oct;9(19):1312-20. doi: 10.1038/sj.gt.3301792. Gene Ther. 2002. PMID: 12224014

10

Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments.

Emerson M, Renwick L, Tate S, Rhind S, Milne E, Painter HA, Boyd AC, McLachlan G, Griesenbach U, Cheng SH, Gill DR, Hyde SC, Baker A, Alton EW, Porteous DJ, Collie DD. Emerson M, et al. Among authors: gill dr. Mol Ther. 2003 Oct;8(4):646-53. doi: 10.1016/s1525-0016(03)00233-8. Mol Ther. 2003. PMID: 14529838 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters